Filing Flows › Addus HomeCare (ADUS) › Q3 2025
Addus HomeCare (ADUS) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 4, 2025
Addus HomeCare (ADUS) reported revenue of $362M for the third quarter 2025 (Q3 2025), +25% from a year earlier and +4% from the quarter before. Operating margin was 9.1%, net earnings $22.8M (6.3% of revenue).
Addus HomeCare, Q3 2025: revenue $362M (+25% year over year), operating margin 9.1%, net earnings $22.8M, operating cash flow $51.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $362M | +4% | +25% |
| Gross profit | $117M | +2% | +27% |
| Operating profit | $32.9M | +0.2% | +27% |
| Net earnings | $22.8M | +4% | +13% |
| Operating cash flow | $51.3M | +128% | +6% |
| Free cash flow | $49.3M | +132% | +6% |
What changed
Revenue was $362.3M in Q3 2025, up 25% year over year and up 4% from the previous quarter.
Gross margin was 32.2%, up 0.4 points from a year earlier. Operating profit was $32.9M, a 9.1% margin (up 0.1 points year over year). Of the extra revenue versus a year earlier, 10% reached operating profit, above the 9% margin then. Operating expenses grew 26% against revenue growth of 25%. The fastest-growing cost line was Other operating costs (+28%). Net earnings were $22.8M, up 13% year over year. The effective tax rate was 24.7%.
Operating cash flow was $51.3M (up 6% year over year), 224% of net earnings. Non-cash charges added back $4.4M of depreciation and amortization and $4.3M of share-based compensation. Working capital and other items added $19.7M. Capital expenditures of $1.9M left free cash flow of $49.3M.
Questions
What was Addus HomeCare's revenue in the third quarter 2025?
Addus HomeCare (ADUS) reported revenue of $362M for the third quarter 2025 (Q3 2025), +25% from a year earlier and +4% from the quarter before.
Was Addus HomeCare profitable in the third quarter 2025?
Operating profit was $32.9M (9.1% of revenue) and net earnings $22.8M.
Source: Addus HomeCare 10-Q on SEC EDGAR.